PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.792
+0.012 (1.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
PAVmed Market Cap
PAVmed has a market cap or net worth of $8.76 million as of February 21, 2025. Its market cap has decreased by -45.56% in one year.
Market Cap
8.76M
Enterprise Value
42.45M
1-Year Change
-45.56%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $8.76M, a decrease of -94.93%. That is a compound annual growth rate of -29.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 8.60M | 24.64% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |